Carl Icahn takes proxy fight to Illumina: report

Carl Icahn takes proxy fight to Illumina: report

Source: 
Endpoints
snippet: 

A proxy fight is brewing at Illumina as activist investor Carl Icahn readies for an argument that the DNA sequencer is costing shareholders billions by following through with its Grail purchase.